// App-Quantinova.ai

: Translationally Controlled Tumour Protein: A Novel Therapeutic Target for Lymphangioleiomyomatosis?

Researchers

Presenter

  • M. Ho

Principal Investigators

  • M. S. Ho

  • D. J. Stewart

Medical Centers

  • Sinclair Centre for Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

  • Laminin

Drug/Treatment

  • staurosporine

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved